IGBA Impresses Importance Of Off-Patent Industry On WHO
CEO Advisory Committee Speaks Directly With WHO Leaders At October Meeting
The IGBA’s CEO advisory committee has met with WHO leaders, including director-general Tedros Adhanom Ghebreyesus, to impress upon them the importance of the generics and biosimilars industry in global patient care and the contribution made during the COVID-19 pandemic.
